Chartwell Pharmaceuticals Information

Chartwell Pharmaceuticals is a US-based, full-service manufacturing, packaging, laboratory, and related supply chain services organization with manufacturing locations in Congers, Carmel and Amityville, New York and a dedicated beta-lactam facility in Toronto, Canada. The highest quality prescription pharmaceutical products have been produced in our cGMP compliant facilities for over 25 years. Our exceptional hands-on leadership team and technical staff bring decades of pharmaceutical industry experience in manufacturing, research & development and analytical services . Our expertise includes developing, transferring, optimizing, and reliable manufacturing of trusted quality products. As a result of our corporate development strategy, our significant plant expansions and acquisitions and investment in new dosage forms and technologies, Chartwell continues to grow our business and broaden our technical and service offerings. We can readily meet the demands of our clients and partners throughout the product life cycle, from API characterization through formulation trials, clinical supplies and full-scale commercial batches. With a continously growing catalog of Orange Book listings - now numbering nearly 1,200 - Chartwell is in the top five largest US generic pharmaceutical manufacturers in terms of ANDA holdings. Our 750+ commercialized NDCs include a recent expansion into a full Beta-Lactam product line, Unit Dose Liquids and a soon-to-launch Semi-Solids portfolio. Chartwell markets over 20 SKUs that represent sole-source industry offerings and another 60+ where we are one of only two suppliers. Chartwell products meet the qualifications and growing demand for both Trade Act Agreement (TAA) and Buy American Act (BAA) compliant products.